000			03513cam a2200493Ia 4500
001			ocn960901823
003			OCoLC
005			20190328114817.0
006			m o d
007			cr |n|||||||||
008			161018s2017 enk ob 001 0 eng d
040			_aYDX _beng _epn _cYDX _dN$T _dIDEBK _dEBLCP _dN$T _dOPELS _dOCLCF _dOCLCQ _dGGVRL _dOCLCQ _dOTZ _dOCLCA _dOCLCQ _dUMR _dU3W _dD6H _dUMR
019			_a966175397
020			_a9780128025420 _q(electronic bk.)
020			_a0128025425 _q(electronic bk.)
020			_z9780128023020
020			_z0128023023
035			_a(OCoLC)960901823 _z(OCoLC)966175397
050		4	_aQR189
072		7	_aMED _x071000 _2bisacsh
082	0	4	_a615.372 _223
245	0	0	_aHuman vaccines : emerging technologies in design and development / _h[electronic resource] _cedited by Kayvon Modjarrad, MD, PhD, Wayne C. Koff, PhD.
260			_aLondon : _bAcademic Press, _c2017.
264		4	_c�2017
300			_a1 online resource
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
504			_aIncludes bibliographical references and index.
588	0		_aOnline resource, title from PDF title page (EBSCO, viewed October 24, 2016).
520			_aHuman Vaccines: Emerging Technologies in Design and Development discusses the advances in molecular biology, biophysics, and informatics-among other disciplines-that have provided scientists with the tools to create new vaccines against emerging and re-emerging pathogens. For example, the virus-like particle technologies that led to licensing of highly efficacious HPV vaccines have only come into full realization in the last 10 years. Their success has, in turn, accelerated the pace with which nanoparticle vaccines are being developed Given the rapidity with which the field is changing and the absence of any text documenting this change, there is a need for a resource that surveys these new vaccine technologies, assesses their potential, and describes their applications. This book provides that resource and complements traditional vaccinology books, but also serves as an excellent standalone for researchers and students with basic knowledge in immunology.
505	0		_aPart I. Designing vaccines from a new starting point : Broadly neutralizing antibodies / L. Morris and T.A. Moody -- part II. Pathogen free vaccines : Replication-competent viral vectors for vaccines delivery / C.L. Parks ; Reverse vaccinology: exploiting genomes for vaccines design / E. Del Tordello, R. Rappuoli and I. Delany ; Virus-like particle and nanoparticle vaccines / M. Kanekiyo and C.B. Buck -- part III. Immune monitoring : Systems vaccinology / M. Rolland and M.A. Eller ; Immunogenetics and vaccination / M. John, S. Gaudieri and S. Mallal -- part IV. Advanced vaccine development : Methodical considerations / P.B. Gilbert and R. Gottardo ; Vaccine development in special populations / K.M. Edwards and C.B. Creech.
650		0	_aVaccines _xBiotechnology.
650		0	_aVaccines _xDesign.
650		0	_aVaccination.
650		7	_aMEDICAL _xPharmacology. _2bisacsh
650		7	_aVaccination. _2fast _0(OCoLC)fst01163544
650		7	_aVaccines _xBiotechnology. _2fast _0(OCoLC)fst01163574
650		7	_aVaccines _xDesign. _2fast _0(OCoLC)fst01163576
655		4	_aElectronic books.
700	1		_aModjarrad, Kayvon, _eeditor.
700	1		_aKoff, Wayne C., _eeditor.
856	4	0	_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9780128023020
999			_c247453 _d247453